Private Trust Company’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.41K Hold
299
﹤0.01% 2002
2025
Q4
$8.81K Buy
299
+107
+56% +$2.97K ﹤0.01% 1983
2025
Q3
$4.85K Buy
192
+80
+71% +$1.95K ﹤0.01% 2158
2025
Q2
$2.69K Sell
112
-151
-57% -$3.5K ﹤0.01% 2206
2025
Q1
$6.02K Hold
263
﹤0.01% 1962
2024
Q4
$6.66K Buy
263
+82
+45% +$2.08K ﹤0.01% 1884
2024
Q3
$4.51K Sell
181
-67
-27% -$1.98K ﹤0.01% 1982
2024
Q2
$7.35K Hold
248
﹤0.01% 1794
2024
Q1
$7.48K Hold
248
﹤0.01% 1761
2023
Q4
$7.09K Hold
248
﹤0.01% 1791
2023
Q3
$9.19K Sell
248
-59
-19% -$2.25K ﹤0.01% 1628
2023
Q2
$12K Buy
307
+195
+174% +$7.64K ﹤0.01% 1558
2023
Q1
$4.09K Hold
112
﹤0.01% 1908
2022
Q4
$3K Buy
+112
New +$3.48K ﹤0.01% 1961

Other funds holding RTO

Private Trust Company's RTO Position: Q1 2026 in Review

Private Trust Company held its Rentokil (RTO) position steady in Q1 2026 at 299 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

Private Trust Company first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $12K in Q2 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Private Trust Company held 299 shares of Rentokil worth $9.41K as of Q1 2026.
  • Private Trust Company left its Rentokil share count unchanged in Q1 2026.
  • Rentokil made up ﹤0.01% of Private Trust Company's portfolio in Q1 2026, its #2002 holding.
  • Private Trust Company first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • Private Trust Company's Rentokil position peaked at $12K in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.